AI in Drug Discovery Market Trends, Growth and Market Size Analysis 2035
According to Payal Rabde, who specializes in artificial intelligence in healthcare, pharmaceutical innovation, and life sciences, with 5+ years of experience in market research and industry analysis, the AI in Drug Discovery Market is entering a phase of rapid expansion, driven by advances in AI-powered drug development, increasing R&D investments, and growing adoption across pharmaceutical and biotechnology companies. His research indicates the market will grow from USD 24.51 billion in 2026 to USD 160.49 billion by 2035 at a 23.22% CAGR, with preclinical and clinical testing, oncology, and machine learning leading demand. He also identifies North America as the current market leader, Asia Pacific as the fastest-growing region, and highlights companies including IBM, Exscientia, Insilico Medicine, Google DeepMind, BenevolentAI, Atomwise, insitro, and Aitia as key innovators shaping the competitive landscape.
Last Updated : 06 August 2026
Category: Healthcare IT
Insight Code: 5010
Format: PDF / PPT / Excel